CRIS Current Research Information System

CAPELLARI, SABINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.181
AS - Asia 8.789
EU - Europa 8.762
SA - Sud America 672
AF - Africa 589
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.042
SG - Singapore 2.816
CN - Cina 2.447
GB - Regno Unito 2.254
IT - Italia 1.976
VN - Vietnam 1.571
DE - Germania 1.230
HK - Hong Kong 772
SE - Svezia 741
BR - Brasile 496
IN - India 474
RU - Federazione Russa 447
UA - Ucraina 380
FR - Francia 351
IE - Irlanda 331
NL - Olanda 329
KR - Corea 261
CI - Costa d'Avorio 177
FI - Finlandia 166
ZA - Sudafrica 156
SC - Seychelles 138
EE - Estonia 132
JP - Giappone 114
AT - Austria 98
JO - Giordania 83
ID - Indonesia 80
TG - Togo 80
CA - Canada 75
AR - Argentina 66
BG - Bulgaria 65
CH - Svizzera 52
MX - Messico 51
BE - Belgio 46
ES - Italia 37
EC - Ecuador 28
PL - Polonia 28
BD - Bangladesh 25
GR - Grecia 25
CO - Colombia 24
AU - Australia 21
UZ - Uzbekistan 20
TR - Turchia 19
IQ - Iraq 14
IR - Iran 14
LT - Lituania 14
PE - Perù 13
PY - Paraguay 13
CL - Cile 11
VE - Venezuela 11
HR - Croazia 10
NG - Nigeria 10
PH - Filippine 10
RO - Romania 10
AE - Emirati Arabi Uniti 8
LB - Libano 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
MY - Malesia 7
IL - Israele 6
PK - Pakistan 6
SA - Arabia Saudita 6
TH - Thailandia 6
HU - Ungheria 5
MA - Marocco 5
TN - Tunisia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
PT - Portogallo 4
EG - Egitto 3
KE - Kenya 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
Totale 30.999
Salva come PNG Salva come JPEG
Città #
Southend 1.983
Singapore 1.839
Ashburn 1.282
Fairfield 1.187
Houston 1.004
Chandler 935
Hong Kong 763
Dong Ket 630
Hefei 597
Ann Arbor 594
Woodbridge 588
Seattle 572
Wilmington 526
Bologna 460
Cambridge 450
Princeton 409
Beijing 338
Dublin 331
Santa Clara 330
Boardman 268
Seoul 254
Dallas 253
Jacksonville 224
Abidjan 177
Ho Chi Minh City 172
Nanjing 164
Westminster 161
Redmond 148
Los Angeles 146
Hanoi 140
Turin 134
Berlin 128
Padova 127
Munich 122
Milan 114
Helsinki 110
Tokyo 108
Buffalo 97
Redondo Beach 94
New York 93
Florence 91
Amman 83
Lomé 80
Jinan 78
Shenyang 76
Saint Petersburg 74
San Diego 74
Bengaluru 65
Sofia 64
São Paulo 59
Vienna 59
Changsha 55
Hebei 55
Medford 54
Tianjin 53
Nanchang 51
Frankfurt am Main 48
Jakarta 48
Nuremberg 46
Brussels 45
Des Moines 45
Mülheim 44
Lappeenranta 43
London 43
Shanghai 42
Guangzhou 39
Olalla 39
Chicago 36
Rome 32
Verona 32
Yubileyny 32
Falls Church 30
Zhengzhou 30
Jiaxing 29
Toronto 29
Amsterdam 28
Dearborn 28
Imola 28
Phoenix 26
Redwood City 26
Bern 25
Haikou 25
Mahé 24
Boydton 23
Bremen 23
Norwalk 23
Da Nang 22
Mexico City 22
Falkenstein 20
Hangzhou 20
San Francisco 20
Warsaw 19
Rio de Janeiro 18
Forlì 17
Montreal 17
Moscow 17
Ningbo 17
Taiyuan 17
Taizhou 17
Boston 16
Totale 20.393
Salva come PNG Salva come JPEG
Nome #
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding 558
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 494
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 304
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 286
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 281
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 254
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 254
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 235
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 227
A case of fatal familial insomnia in Africa. 218
Messenger RNA processing is altered in autosomal dominant leukodystrophy 215
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 214
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 212
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 206
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 204
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 199
Benign tremulous parkinsonism in a patient with dardarin mutation. 197
The RET51/FKBP52 complex and its involvement in Parkinson disease. 197
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 195
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 194
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 193
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 193
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 192
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 191
Binary transformation of sequencing data to explore functional genetic patterns. 190
A new potential biomarker for dementia with Lewy bodies 189
Age at onset in genetic prion disease and the design of preventive clinical trials 189
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 183
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 183
Color choice preference in cognitively impaired patients: A look inside alzheimer’s disease through the use of lüscher color diagnostic 183
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 182
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 182
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 182
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 181
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 177
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 176
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 176
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 176
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 173
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 173
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 173
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 172
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 172
Lack of association between five serotonin metabolism-related genes and medication overuse headache 168
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 168
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 167
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 166
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 165
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 164
Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? 164
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 161
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 160
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 159
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 159
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 159
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 158
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 156
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 156
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 154
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 153
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 152
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 151
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients 151
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 151
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 150
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 150
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 148
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 148
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 148
Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer’s Disease 147
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 146
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 145
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 145
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 144
Nuclear lamins: Functions and clinical implications 144
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 144
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 144
Multimodal investigation of melanopsin retinal ganglion cells in Alzheimer's disease 143
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 143
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 143
Neurosyphilis orofacial dyskinesia: the candy sign. 143
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 142
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 142
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 141
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 140
Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: Insights into phenotypic variability and disease pathogenesis. 140
Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients 140
Quantifying prion disease penetrance using large population control cohorts 139
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 139
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 138
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 138
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 137
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 137
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 137
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 136
The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. 135
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 135
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 135
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 134
Fragile X premutation tremor/ataxia syndrome (FXTAS): a case with characteristic clinical and MR features. 134
Totale 17.761
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.409 0 0 0 0 0 188 145 257 290 202 136 1.191
2021/20224.007 386 138 246 212 350 187 87 418 186 382 797 618
2022/20234.230 444 549 192 544 313 298 155 279 708 110 403 235
2023/20241.268 84 182 107 137 109 172 79 110 43 107 75 63
2024/20255.185 239 750 411 362 671 280 468 186 158 452 225 983
2025/20266.474 969 1.328 1.329 1.050 1.451 347 0 0 0 0 0 0
Totale 31.647